New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in US – Lung Disease News


Lung Disease News

New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in US
Lung Disease News
Boehringer Ingelheim Pharmaceuticals recently announced that SPIRIVA RESPIMAT, a new inhaled medicine for maintenance treatment of asthma, is now available by prescription in U.S. pharmacies for adults and adolescents. The U.S. Food and Drug …
SPIRIVA® RESPIMAT® Now Available in the US for Maintenance Treatment of Asthma in Adults and AdolescentsBusiness Wire India (press release)

all 2 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.